Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
3 trial readouts that could shake up the obesity market this year
Galapagos unveils plan to split, hiving off its drugs unit
*please scroll down for all the latest news*
